Antigen monitoring system

• US 20080319289A1
• Filed: 06/22/2007
• Published: 12/25/2008
• Est. Priority Date: 06/22/2007
• Status: Active Grant

• Current Assignee: Marlon Williams
• Original Assignee: Marlon Williams
• Inventors: Williams, Marlon
• Granted Patent: US 8,463,344 B2
• Time in Patent Office: Days
• US Class Current: 600/322
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: C12Q 1/6886 for cancer immunoassay for cancer G01N33/574

Abstract

A method for detecting cancer in a subject includes administering polysilicon mirrors to the subject, transmitting near infrared light through subject'"'"'s skin, receiving light which is reflected from the polysilicon mirrors though the subject'"'"'s skin, converting received light into a digital signal and calculating a level of CEA in the subject'"'"'s blood from the digital signal.

Claims

1. A device for detecting cancer in a subject, comprising:

an infrared sensor for emitting near infrared light to penetrate the subject'"'"'s skin;

an analog to digital converter for converting an analog signal from the infrared sensor to a digital signal; and

a microcontroller to calculate a carcinoembryonic antigen (CEA) level in the subject'"'"'s blood stream.

2. The device of claim 1, further comprising a read-only memory for storing an output of the microcontroller.

3. The device of claim 2, further comprising a communication device for transmitting the output of the microcontroller stored in the read-only memory to another device.

4. The device of claim 3, wherein the communication device is a cellular modem.

5. The device of claim 3, wherein the communication device communicates with the another device over an Internet.

6. The device of claim 1, wherein the microcontroller calculates a change in a CEA level in the subject'"'"'s blood stream.

7. The device of claim 1, wherein the infrared sensor receives light reflected from polysilicon mirrors in the subject'"'"'s blood.

8. A method for detecting cancer in a subject, comprising:

administering polysilicon mirrors to the subject;

transmitting near infrared light through subject'"'"'s skin;

receiving light which is reflected from the polysilicon mirrors though the subject'"'"'s skin;

converting received light into a digital signal; and

calculating a level of CEA in the subject'"'"'s blood from the digital signal.

9. The method of claim 8, wherein differences in the level of CEA in a subject'"'"'s blood are determined based on previously stored measurements and currently taken measurements.

10. The method of claim 8, wherein the level of CEA is stored.

11. The method of claim 10, wherein the level of CEA is transmitted to a third party.

12. The method of claim 11, wherein the level of CEA is transmitted to the third party via an Internet.

13. The method of claim 8, wherein an intensity of light reflected from the polysilicon mirrors varies according to an amount of antigen markers in the subject'"'"'s blood.

14. A device for detecting cancer in a subject, comprising:

a retroreflective photoelectric sensor for emitting near infrared light to penetrate the subject'"'"'s skin;

an analog to digital converter for converting an analog signal from the infrared sensor to a digital signal;

a plurality of microcontrollers to calculate a carcinoembryonic antigen (CEA) level in the subject'"'"'s blood stream; and

a communication device to communicate the CEA level.